Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vanda Pharmaceuticals Inc.    VNDA   US9216591084

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
07/25/2014 07/28/2014 07/29/2014 07/30/2014 07/31/2014 Date
14.18(c) 14(c) 14.11(c) 14.74(c) 14.7(c) Last
342 737 432 321 432 926 350 045 508 670 Volume
+1.87% -1.27% +0.79% +4.46% -0.27% Change
More quotes
Company
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on the development and commercialization of products for the treatment of central nervous system disorders. Its product portfolio includes Fanapt and Tasimelteon. The Fanapt product is a compound for the treatment of schizophrenia,... 
Surperformance© rating of Vanda Pharmaceuticals Inc.
Trading Rating : Investor Rating :
More about the company
Chart VANDA PHARMACEUTICALS INC.
Duration : Period :
Vanda Pharmaceuticals Inc. Technical Analysis Chart | VNDA | US9216591084 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 45,4 M
EBIT 2014 -77,4 M
Net income 2014 -83,2 M
Debt 2014 -
Yield 2014 -
Sales 2015 99,2 M
EBIT 2015 -24,4 M
Net income 2015 -38,8 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 11,0x
Capi. / Sales 2015 5,03x
Capitalization 499 M
More Financials
Latest news on VANDA PHARMACEUTICALS INC.
1d ago VANDA PHARMACEUTICALS : Patent Issued for Treatment of Circadian Rhythm Disorder..
07/23 VANDA PHARMACEUTICALS : Assigned Patent
07/17 VANDA PHARMACEUTICALS : to Announce Second Quarter 2014 Financial Results on Aug..
07/17 VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/16 VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/12 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ™ tasimel..
06/10 VANDA PHARMACEUTICALS : Other Events (form 8-K)
06/04 WEDNESDAY'S ETF MOVERS : Xbi, gxc
06/04 VANDA PHARMACEUTICALS : Regulation FD Disclosure, Financial Statements and Exhib..
06/03 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ™ (tasime..
06/03 VANDA PHARMACEUTICALS : Other Events, Financial Statements and Exhibits (form 8-..
06/03 VANDA PHARMACEUTICALS : European Medicines Agency Accepts HETLIOZ(TM) (tasimelte..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Technical analysis
Income Statement Evolution
Vanda Pharmaceuticals Inc. : Income Statement Evolution
More Financials
EPS Revisions
Vanda Pharmaceuticals Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF